Gurugram-based Zoplar has raised $3.4 million in a Series A funding round led by Blume Ventures. Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX also participated in the round. This brings the total funding secured by the company to $5.1 million, with prior contributions from Titan Capital, Stride Ventures, and Panthera Peak.
Zoplar is a platform that aims to streamline the medical equipment procurement process for small and medium-sized hospitals in India. The company plans to use the newly raised funds to strengthen its operational capabilities by focusing on backward integration in the supply chain and developing a robust service engineering team. India’s healthcare infrastructure is undergoing rapid transformation, with MSME hospitals playing a critical role in bridging existing gaps.
However, these hospitals often face challenges in identifying cost-effective medical equipment, managing vendor relationships, ensuring quality after-sales service, and securing financing solutions.
Zoplar’s growth in healthcare procurement
Zoplar is addressing these issues by developing a full-stack medical equipment platform tailored to meet their needs.
Co-founders Amit Sah and Umesh Sharma launched Zoplar in 2022 after identifying these pain points through extensive research. They combined their expertise in healthcare and operations to create a platform that simplifies the medtech procurement and after-sales experience for MSME hospitals. “This investment is not just financial backing—it’s a validation of our mission to make quality healthcare accessible through affordable and reliable medical technologies,” stated Amit Sah and Umesh Sharma.
“It motivates us to scale our impact, enhance our offerings, and continue empowering healthcare providers to deliver uninterrupted care.”
Since its inception, Zoplar claims to have partnered with over 300 hospitals, including leading nephrology chains like DCDC, and boasts a 40% repeat customer rate. This underscores the demand for its solutions in India’s evolving healthcare sector. Sajith Pai of Blume Ventures highlighted, “We believe in Zoplar’s vision and their capacity to improve India’s healthcare landscape.
Their commitment to addressing critical procurement and service challenges aligns with our focus on ventures driving meaningful societal change.”
